Hottest Incredible Stocks (LZB, USG, GERN, CTRP)

New York, NY -- (SBWIRE) -- 10/19/2012 -- La-Z-Boy Incorporated (NYSE:LZB) is a global producer of reclining chairs. The Company manufactures, markets, imports, distributes and retails upholstery products, accessories and casegoods (wood) furniture products. La-Z-Boy Incorpor (NYSE:LZB) is very active today and traded between $15.85 - 17.13 with total traded volume of 1726143 shares. At a current price of 16.92, LZB is +1.27 - +8.12% from the previous close of $15.65. Moreover, At Current Market Price,LZB is in the distance of +13.03% from its 50-day Moving Average price of $14.9697 and +22.62% from its 200-day Moving Average price of $13.7982.

How Should Investors React To LZB Now? Find Out Here

USG Corporation C (NYSE:USG) is +1.94 - +8.53% from the previous close of $22.73. It traded between $21.30 - 24.85 with total traded volume of 8307633 shares. At Current Market Price, USG is in the distance of +10.88% from its 50-day Moving Average price of $22.2486 and +32.85% from its 200-day Moving Average price of $18.5699. Shares of USG Corp. rose Thursday after the building products maker said its third-quarter loss shrank.USG reported greater drywall sales and said it's seeing "modest" demand gains. USG has struggled financially since the housing downturn began in 2006, but has reported an operating profit for three straight quarters as the housing market comes back to life.The company is also in the process of selling its European operations to a German company for about $80 million, saying that getting rid of that "lower-growth" market will help fund expansion in faster-growing markets, such as India.In the three months ended Sept. 30, the Chicago company reported a loss of $29 million, or 28 cents per share. That's down from a loss of $115 million, or $1.09 per share, a year ago. Revenue rose 9 percent, to $828 million from $763 million.

Can USG Extend Massive Gain? Find Out Here

Geron Corporation (Nasdaq: GERN) announced that it was discontinuing its stem cell research and development programs and its clinical trials of OPC-1, a groundbreaking product to treat spinal cord injuries manufactured from human embryonic stem cells. Nearly a year has now passed, and Geron has not announced any transaction that would provide value to either Geron or its shareholders from those stem cell assets. Geron Corporation (NASDAQ:GERN) shares gained 8.10% to $1.53 in the morning hour after BioTime Inc. urged Geron shareholders to push Geron's board to sell the company's stem cell assets to BioTime. In November of last year, Geron said it would discontinue the further development of its stem cell programs and will eliminate 38% of its workforce as the company aimed to focus resources on advancing two cancer drug candidates.

Are these stocks a buy or sell? Let us help you decide, Check here

Ctrip.com International, Ltd. (NASDAQ:CTRP) is a travel service provider for hotel accommodations, airline tickets and packaged tours in China. Ctrip aggregates information on hotels and flights and enables its customers to make hotel and flight bookings. Ctrip.com Interna (NasdaqNM:CTRP) is +1.19 - +6.37% from the previous close of $18.67. It traded between $18.48 - 20.43 with total traded volume of 5409522 shares. Keep a close eye on CTRP, as the stock has been showing unusual moves over the past weeks. At Current market price, CTRP has recovered +60.68% from its 52-week Low of 12.36 and has Pulled back -48.19% from its 52-week high of 38.33.

Can CTRP Continue To Move Higher? Find Out Here

DISCLAIMER:

Neither PennyStocksUpdate.biz nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by PennyStocksUpdate.biz, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation.PennyStocksUpdate.biz makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through PennyStocksUpdate.biz. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned here in..

Contact:
PennyStocksUpdate.biz
info@pennystocksupdate.biz